Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VeCollal is a Belgian biotechnology company that has developed the world's first science-based, vegan alternative to human collagen. Utilizing a proprietary biomimetic technology, the company produces a plant-based amino acid profile that identically matches the composition of Type I human collagen. Their flagship product is designed to stimulate the body's own collagen production, offering a sustainable and ethical alternative to traditional animal-derived collagen supplements. VeCollal primarily operates as a B2B supplier, partnering with global brands in the beauty, health, and wellness sectors to integrate their technology into various consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VeCollal.